hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06313840 id: CIP3125 briefTitle: Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction acronym: COG01 overallStatus: RECRUITING date: 2023-08-21 date: 2024-09-30 date: 2024-11-30 date: 2024-03-15 date: 2024-03-15 name: Zoll Medical Corporation class: INDUSTRY briefSummary: Study to assess the prevalence of central sleep apnea in patients with heart failure with reduced or mildly reduced left ventricular ejection fraction (LVEF \<50%) followed by case-control study to assess the link between central sleep apnea and cognitive function conditions: Heart Failure conditions: Central Sleep Apnea studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 200 type: ESTIMATED measure: Prevalence of CSA in tested HFrEF/HFmrEF patients measure: Difference in cognitive function scores between the HFrEF/HFmrEF CSA and no SDB groups using the CANTAB assessment. sex: ALL minimumAge: 50 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Przychodnia na Teczowej status: RECRUITING city: Wrocław country: Poland name: Anna Basinska role: CONTACT name: Ewa Jankowska role: PRINCIPAL_INVESTIGATOR lat: 51.1 lon: 17.03333 facility: Szpital Uniwersytecki we Wrocławiu status: RECRUITING city: Wrocław country: Poland name: Anna Basinska role: CONTACT name: Ewa Jankowska role: PRINCIPAL_INVESTIGATOR lat: 51.1 lon: 17.03333 hasResults: False
nctId: NCT06313827 id: UV-INV_3165929 briefTitle: e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-01 date: 2025-06 date: 2024-03-15 date: 2024-03-15 name: University of Valencia class: OTHER name: Asociación de Fibrosis Quística - Comunidad Valenciana briefSummary: The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life.
Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus telematic control of exacerbations with feedback from the physiotherapist. conditions: Cystic Fibrosis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: TRIPLE maskingDescription: Participants will be randomly assigned to one of three study groups by the person conducting the intervention.
The evaluators are unaware of the assignment at all times. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: Exercise plus Monitoring Group (TG-2) name: Exercise plus monitoring and follow-up group (TGF-3) name: Exercise Group (CG-1) measure: Clinical exacerbation measure: Dyspnea measure: Spirometric function measure: Oxigenation measure: Functional capacity measure: Quality of life (QoL) measure: Motivation to engage in physical activity sex: ALL minimumAge: 6 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Universitat de Valencia city: Valencia zip: 46010 country: Spain name: Francisco Martinez Arnau, PhD role: CONTACT name: Anna Arnal Gomez, PhD role: SUB_INVESTIGATOR name: Sara Cortes Amador, PhD role: PRINCIPAL_INVESTIGATOR name: Francisco Martínez Arnau, PhD role: SUB_INVESTIGATOR name: Carlos Gomez Chinesta, PT role: SUB_INVESTIGATOR lat: 39.46975 lon: -0.37739 hasResults: False
nctId: NCT06313814 id: DE RKEB/IKEB 5622-2020 briefTitle: The Effect of Ginger on Functional Dyspepsia Symptoms and Body Fat Content Among Patients With Functional Dyspepsia overallStatus: ENROLLING_BY_INVITATION date: 2023-06-01 date: 2025-01 date: 2025-12 date: 2024-03-15 date: 2024-04-12 name: University of Debrecen class: OTHER briefSummary: The goal of this clinical trial is to assess ginger's effect on patients with functional dyspepsia.
2. Does ginger intake decrease the body fat content among patients with functional dyspepsia? Dyspepsia patients will be asked to take 540 mg of ginger capsule twice a day. Researchers will assess if there is an improvement in the symptoms of the disease and the fat content. \[ to see if gingers effect. conditions: Functional Dyspepsia studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 62 type: ESTIMATED name: Swanson ginger capsule measure: Functional Dyspepsia Symptom Severity measure: Body Fat Content Analysis measure: Improvement in Quality of Life sex: ALL minimumAge: 18 Years maximumAge: 72 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Debrecen city: Debrecen zip: 4032 country: Hungary lat: 47.53333 lon: 21.63333 hasResults: False
nctId: NCT06313801 id: DPNCD-2309 briefTitle: Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions overallStatus: RECRUITING date: 2023-01-19 date: 2026-01-19 date: 2026-01-19 date: 2024-03-15 date: 2024-03-15 name: Nizhny Novgorod Regional Clinical Oncology Center class: OTHER_GOV briefSummary: After the initial diagnostic laparoscopy the Control group patients undergo 6 courses of polychemotherapy according to the FLOT scheme; the examination is carried out every 3 courses (after the 3rd and the 6th courses) with the control diagnostic laparoscopy after 6 courses of polychemotherapy. In the event of the complete regression of foci along the peritoneum and receiving Cy- in the peritoneal lavage, the dynamic observation or cytoreductive surgery is considered (optionally); in case of the incomplete response the dynamic observation is carried out until progression; in case of progression the 2nd line of chemotherapy or the optimal palliative care options depending on the clinical situation is considered.
nctId: NCT06313788 id: EC007-2324 briefTitle: Applying a Small Procedure Prior to Injection/Vaccination Reduces Pain Experiences in Child Patients overallStatus: NOT_YET_RECRUITING date: 2025-01-01 date: 2026-01-01 date: 2026-01-01 date: 2024-03-15 date: 2024-03-15 name: Lingnan University class: OTHER briefSummary: Pain is common among children. Given that children are not as mature and independent in assessing or treating their pain as adults, they are a relatively vulnerable group in terms of pain management and are in need of additional attention. However, there is still insufficient recognition and treatment of pain in children. Taken the procedure of injection/vaccination in children as an example, child patients usually wait for their turn to take the injection from the nurse/doctor, during which anxiety and fear of pain develop. As children are less able to manage their pain than adults, the fear they develop during the waiting time, together with the pain they actually felt after the treatment, can bring negative experiences to them. In this proposed project, the investigators aim to apply a minor procedure prior to a treatment that induces pain (e.g., injection / vaccination) to help managing pediatric pain. conditions: Pediatric Pain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: SINGLE maskingDescription: One group of the participants will be told that they are involved in a marketing survey and will be given a band-aid as a token of appreciation for their participation. This constitutes the mere possession group. whoMasked: PARTICIPANT count: 100 type: ESTIMATED name: Possession of a customized placebo analgesic band-aid prior to vaccination or injection measure: Pain intensity Rating (rating how much pain participants feel) measure: Pain intensity Measurement (measure how much pain participants feel) measure: Pain Threshold (record the first-time participants feel the pain) measure: Pain unpleasantness (rating how unpleasant participants feel about the pain) measure: Mood (rating the positive and negative emotions of the participants) measure: State-anxiety (Rating the participants' current anxiety level) measure: Fear of pain Rating measure: Magical thinking Rating measure: Pain Self-Efficacy measure: Self-efficacy to tackle pain measure: Expectation of Pain Severity sex: ALL minimumAge: 6 Years maximumAge: 11 Years stdAges: CHILD hasResults: False
nctId: NCT06313775 id: SPS005 briefTitle: Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy overallStatus: ENROLLING_BY_INVITATION date: 2024-06-01 date: 2024-12-31 date: 2024-12-31 date: 2024-03-15 date: 2024-03-15 name: Sanpasitthiprasong Hospital class: OTHER_GOV briefSummary: The goal of this randomized controlled trial is to compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications between SA and SCB groups in metastatic prostate cancer patient. The main question it aims to answer are:
Participants will undergo bilateral orchidectomy. They will be randomly assigned to two groups: the group receiving spinal anesthesia and the group receiving spermatic cord block If there is a comparison group: Researchers will compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications in both groups of patients. conditions: Orchiectomy conditions: Spermatic Cord Block conditions: Spinal Anesthesia conditions: Pain Score conditions: Prostate Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Simple random sampling primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 18 type: ESTIMATED name: bilateral orchiectomy measure: intraoperative pain score measure: post-operative pain score measure: morphine consumption measure: post-operative complications sex: MALE stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Sanpasitthiprasong hospital city: Ubon Ratchathani zip: 33000 country: Thailand lat: 15.23844 lon: 104.84866 hasResults: False
nctId: NCT06313762 id: Codi CEIm: 21/132-P briefTitle: Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers. overallStatus: COMPLETED date: 2022-01-18 date: 2024-01-24 date: 2024-02-08 date: 2024-03-15 date: 2024-03-15 name: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina class: OTHER briefSummary: The objective of this randomized, multicenter, open-label, parallel, controlled clinical trial is to evaluate pain reduction during the administration of two vaccines in children aged 3 and 6 years through virtual reality.
International Registered Report Identifier (IRRID): PRR1-10.2196/35910 conditions: Pain conditions: Pediatrics conditions: Vaccination conditions: Virtual Reality studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The intervention group will use the Pico G2 VR goggles (Pico Interactive Inc) during the administration of the two vaccines, together with an Android AOYODKG tablet, which will be connected to the goggles as a controller.
The control group participants will receive traditional distractors, such as being held by the parent or guardian who accompanies them to the appointment, receiving stickers at the end of the appointment, or receiving rewards that the parent or guardian has prepared from home. primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 300 type: ACTUAL name: Pico G2 Virtual Reality Glasses (Pico Interactive Inc), together with an Android AOYODKG tablet name: Traditional Distractors name: Triple Viral + Varicella Vaccine at 3 years of age name: Hepatitis A + Diphtheria-Tetanus-Pertussis Vaccine at 6 years of age. measure: Evaluation of pain perception during the administration of two vaccines in children aged 3 and 6 years, through the Wong-Baker Pain Scale. measure: Evaluation of anxiety during the administration of two vaccines in children aged 3 and 6 years, through heart rate and the Children's Fear Scale. measure: Degree of satisfaction of parents/legal guardians of minors after the administration of two vaccines, using the CSAT scale. measure: Number of patients who experienced adverse effects during the administration of vaccines and who used virtual reality glasses, through the registration of the effects presented. sex: ALL minimumAge: 3 Years maximumAge: 6 Years stdAges: CHILD facility: Catalan Institute of Health. Territorial Management of Central Catalonia. city: Manresa state: Barcelona zip: 08260 country: Spain lat: 41.72815 lon: 1.82399 hasResults: False
nctId: NCT06313749 id: MMS-US-1 briefTitle: Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-12 date: 2025-12 date: 2024-03-15 date: 2024-03-15 name: Sanoculis Ltd class: INDUSTRY briefSummary: The goal of this clinical trial is to show non-inferiority of the MIMS® device/procedure with Mitomycin-C, in terms of its surgical success rate, compared to trabeculectomy with Mitomycin-C in subjects diagnosed with primary open angle glaucoma, whose intraocular pressure is not controlled despite polypharmacy.
Eligible screened participants will undergo the MIMS® procedure and will be followed for a period of 12 months in this single-arm study. Investigators will compare the results of this study to the surgical success rate of traditional trabeculectomy with Mitomycin-C. conditions: Primary Open Angle Glaucoma conditions: Open Angle Glaucoma studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE maskingDescription: This clinical study is observer masked only when measuring intraocular pressure (using Goldmann Applanation Tonometry). Intraocular pressure measurements will be determined using the 2-person method to reduce bias. Observer 1 (masked to real time reading) will look through the slit lamp and turn the Goldmann Tonometer dial, and Observer 2 will read and record the intraocular pressure readings. Observer 1 will be unable to see the readings with the use of a masking card. count: 129 type: ESTIMATED name: Minimally Invasive Micro Sclerostomy Device measure: Surgical success rate of the MIMS® device/procedure at 12 months after surgery measure: Exploratory Effectiveness Endpoint 1 measure: Exploratory Effectiveness Endpoint 2 measure: Exploratory Effectiveness Endpoint 3 measure: Exploratory Effectiveness Endpoint 4 measure: Safety Outcome 1 measure: Safety Outcome 2 measure: Safety Outcome 3 sex: ALL minimumAge: 40 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06313736 id: STU00220591_shortening id: 2T32MH115882-06A1 type: NIH link: https://reporter.nih.gov/quickSearch/2T32MH115882-06A1 briefTitle: What SSI Duration is Most Effective? An Online Experiment With American Adults overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-20 date: 2024-05 date: 2024-05 date: 2024-03-15 date: 2024-04-11 name: Northwestern University class: OTHER name: National Institute of Mental Health (NIMH) briefSummary: In a previous study (https://osf.io/qdznc), the research team found that an 8-minute version of a single-session intervention for loneliness was more effective than a 23-minute version of it. The present work aims to further explore the relationship between intervention duration and effectiveness.
In this online trial, participants will be randomized to a 15-minute single-session depression intervention called the Action Brings Change (ABC) Program, a 10-minute version of it, a 6-minute version of it, or a 2-minute version of it. The main analysis will evaluate how change in depressive symptoms over eight weeks differs across conditions. conditions: Depression studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Participants will be assigned to one of four different conditions. primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: Participants will be aware that they will be assigned to an intervention designed to help them with depressive symptoms. They will know that the study compares multiple interventions but will not know to which arm they have been assigned. Additionally, the measures will be self-administered, so there is no scope for evaluator bias. There will be no interaction between participants and investigators. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 1100 type: ESTIMATED name: Action Brings Change Project (15-minute adult version) name: Action Brings Change Project (10-minute adult version) name: Action Brings Change Project (6-minute adult version) name: Action Brings Change Project (2-minute adult version) measure: Change in Patient Health Questionnaire-8 at 8 weeks (PHQ-8; Kroenke et al., 2009) measure: Change in Beck Hopelessness Scale at 8 weeks (BHS-4; Perczel Forintos et al., 2013) measure: Change in Beck Hopelessness Scale - 4-item at post-intervention measure: Change in UCLA Loneliness Scale 3-item version at 8-week follow-up (ULS-3; Hughes et al., 2004) measure: Presence of an "Aha! moment" at post-intervention measure: Presence of an "Aha! moment" at 8 weeks post-intervention measure: Significance of the "Aha! moment" at immediately post-intervention measure: Significance of the "Aha! moment" at 8 weeks post-intervention measure: Change in Frequency of actions and thoughts scale at post-test at 8 weeks post-intervention (FATS; Terides et al., 2016) measure: Expected improvement at post-intervention (from the Credibility / Expectancy Questionnaire; Devilly, 2004) measure: Self-reported improvement at 8-weeks post-intervention (adapted from the Credibility/ Expectancy Questionnaire; Devilly, 2004) measure: Intervention satisfaction star rating at post-intervention measure: Intervention satisfaction star rating at 8 week follow-up sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Northwestern University Medical Social Sciences city: Chicago state: Illinois zip: 60611 country: United States lat: 41.85003 lon: -87.65005 typeAbbrev: Prot_SAP hasProtocol: True hasSap: True hasIcf: False label: Study Protocol and Statistical Analysis Plan date: 2024-03-17 uploadDate: 2024-03-17T16:12 filename: Prot_SAP_000.pdf size: 81821 hasResults: False
nctId: NCT06313723 id: SBÜ-AYDINKARTAL-030 briefTitle: The Effect of Mother's Anxiety, Fear and Prenatal Connection in the Prenatal Education Given to Pregnant Women Via Podcast During the Non-stress Test overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-08-30 date: 2024-10-31 date: 2024-03-15 date: 2024-03-15 name: YASEMİN AYDIN KARTAL class: OTHER briefSummary: This study was planned to determine the effect of prenatal education given via podcast to nulliparous pregnant women who applied to the Non-Stress Test Polyclinic of the University of Health Sciences, Istanbul Bagcilar Training and Research Hospital, on maternal anxiety, fear and fetal attachment. The research, planned in a randomized controlled quasi-experimental design, will be carried out with nulliparous pregnant women (n:104) who apply to the Non-Stress Test polyclinic of the University of Health Sciences Istanbul Bağcılar Training and Research Hospital. Pregnant women who voluntarily participate in the research will be divided into intervention (n: 52) and control (n: 52) groups according to the computer-assisted simple random sampling technique. The intervention group, nulliparous pregnant women, will listen to 3 podcasts of 5-6 minutes. Pregnant women in the control group will be given a booklet on the pregnancy and birth process from the Ministry of Health as part of routine care. "Personal Information Form", "State-Trait Anxiety Inventory", "Wijma Birth Expectation/Experience Scale Version A" and "Prenatal Attachment Inventory" will be applied to all pregnant women included in the study. conditions: Prenatal Education studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized controlled single-blind quasi-experimental study primaryPurpose: OTHER masking: SINGLE maskingDescription: Single (Participant) Which of the participants is the control or intervention group will be selected by randomization. whoMasked: PARTICIPANT count: 104 type: ESTIMATED name: Prenatal education management delivered via podcast measure: Introductory Information Form measure: State-Trait Anxiety Inventory(D-SKE) measure: Wijma Birth Expectation/Experience Scale Version A (W-DEQ A) measure: Prenatal Attachment Inventory (PBI) measure: State-Trait Anxiety Inventory(D-SKE) measure: Wijma Birth Expectation/Experience Scale Version A (W-DEQ A) measure: Prenatal Attachment Inventory (PBI) sex: FEMALE minimumAge: 18 Years maximumAge: 35 Years stdAges: ADULT facility: University of Health Sciences city: Istanbul zip: 34668 country: Turkey lat: 41.01384 lon: 28.94966 hasResults: False
nctId: NCT06313710 id: Y (2024) 058 briefTitle: Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES4) overallStatus: NOT_YET_RECRUITING date: 2024-05-10 date: 2026-12-01 date: 2026-12-01 date: 2024-03-15 date: 2024-04-19 name: General Hospital of Shenyang Military Region class: OTHER briefSummary: This is a prospective, randomized, open label, blinded-end point, single-center study, aiming to investigate the effect of head down position in anterior circulation large vessel occlusion patients with successful recanalization after endovascular treatment. conditions: Ischemic Stroke studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 90 type: ESTIMATED name: head down position measure: Changes in National Institute of Health stroke scale (NIHSS) measure: proportion of excellent functional outcome measure: proportion of favorable functional outcome measure: ordinal distribution of modified Rankin Score (mRS) measure: early neurological improvement (ENI) measure: changes in infarct volume measure: changes in cerebral edema measure: Changes in National Institute of Health stroke scale (NIHSS) measure: new stroke or other vascular event(s) measure: proportion of sympomatic intracranial hemorrhage measure: proportion of intraparenchymal hemorrhage (PH) measure: percentage of severe adverse events measure: all-cause mortality measure: changes in dynamic cerebral autoregulation (dCA) measure: changes in cortical oxygen saturation measure: changes in serum biomarkers sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Department of Neurology, General Hospital of Northern Theater Command city: Shenyang zip: 110016 country: China name: Hui-Sheng Chen, Ph.D. role: CONTACT phone: +86 13352452086 email: chszh@aliyun.com lat: 41.79222 lon: 123.43278 hasResults: False